Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center One of the world’s leading comprehensive cancer centers. To make an appointment, call (844)-422-9799
(4312)

Connect with us:
www.mskcc.org
https://twitter.com/MSKCancerCenter
www.instagram.com/memorialsloankettering
youtube.com/user/mskcc

Our main campus and inpatient hospital are located on the Upper East Side of Manhattan. We also have outpatient facilities in Commack, Uniondale, and Hauppauge on Long Island, New York; West Harrison in Westchester County, New York; and Basking Ridge, Montvale, and Middletown in New Jersey; as well as several locations in New York City.

Maureen once wondered if she would ever feel like herself again. After her light chain (AL) amyloidosis returned followi...
02/18/2026

Maureen once wondered if she would ever feel like herself again. After her light chain (AL) amyloidosis returned following a second stem cell transplant, everyday tasks – even walking – became more difficult.

In July 2024, Maureen joined a CAR T cell therapy clinical trial at MSK, led by Dr. Heather Landau. Just days later, she noticed a change. Maureen remembers telling her husband, “I know this sounds crazy, but I’m walking in the hall, I don’t have chest tightness, and my legs are picking up like the good old days.”

Ten days after leaving the hospital, Maureen walked four miles with her family. Soon after, she climbed 137 steps to the top of Montauk Point Lighthouse. Today, she is hiking, biking, and traveling again with the people she loves.

Learn from physician scientist Dr. Karlo Perica how this immunotherapy is changing what is possible for patients like Maureen: https://bit.ly/3OnfCQ3

02/17/2026

Love was in the air...and at the MSK Caring Canines Kissing Booth. ❤️

Bear, Mancha, Marcello, Nellie, Oliver, and Oscar proudly represented our MSK Caring Canines to spread Valentine's Day love and comfort to MSK patients and staff. DYK our dedicated teams of therapy dogs visit more than 9,000 patients every year?

02/17/2026

For more than 20 years, Maureen lived with light chain (AL) amyloidosis, a rare and relentless blood disease. Then she enrolled in a CAR T cell clinical trial made possible by years of research at Memorial Sloan Kettering Cancer Center (MSK).

The trial was led by MSK bone marrow transplant specialist Dr. Heather Landau. It uses a patient’s own immune cells that have been re-engineered to fight disease – the focus of research by physician scientist Dr. Karlo Perica, who is building on MSK's pioneering work in CAR T therapy more than a decade ago.

Just one week after her CAR T-cell infusion, Maureen’s blood tests were all normal, and she felt great.

Watch more Saved by Science stories on our YouTube 🧬

“I was basically told that I had a rare and aggressive cancer three weeks before we were going to go on the road.” For y...
02/13/2026

“I was basically told that I had a rare and aggressive cancer three weeks before we were going to go on the road.”

For years, Mary-Kate, 34, and her husband, Scott, had been planning to pursue a life on the road living in a van. In March 2024, during a series of health check-ups ahead of this new adventure, Mary-Kate's doctor recommended that she get a mammogram due to her family history of breast cancer.

The mammogram came back showing a cluster of concerning calcifications, and a biopsy confirmed she had triple negative breast cancer. “If we hadn’t planned to begin full-time van life, I would have never made that appointment,” says Mary-Kate.

Mary-Kate and Scott postponed their plans and she began treatment at MSK Monmouth with MSK breast surgeon Dr. Laurie Kirstein, breast oncologist Dr. Adam Widman, and radiation oncologist Dr. Beryl McCormick. Her treatment plan included a lumpectomy, three months of chemotherapy with scalp cooling, and 20 rounds of radiation.

In September 2024, she rang the end-of-treatment bell and was declared NED (no evidence of disease) in October 2024.

Today, Mary-Kate, Scott, and their dog, Floyd, are now happily on the road, prioritizing the healing benefits of being in nature. “My body feels strong again. The visual remnants of what chemotherapy did to my body have slowly evaporated,” Mary-Kate says. “Fear has loosened its grip on me, and my confidence is slowly returning. I’ve reclaimed my life, and it feels richer than ever before.”

Her advice for other young adults diagnosed with cancer: Sometimes age can act as a discriminating factor when it comes to health, but push to get seen; to get screenings; to advocate for yourself.

“When you’re first diagnosed with cancer, you just stop and think, ‘OK, how many years do I have left, and what do I nee...
02/11/2026

“When you’re first diagnosed with cancer, you just stop and think, ‘OK, how many years do I have left, and what do I need to get done in those years?’” says Ellen, an MSK ovarian cancer patient. “I never thought my life would be extended like this. Now it’s exciting to think, maybe I’ll get to meet my grandkids.”

By participating in an MSK clinical trial, led by gynecological oncologist Dr. Rachel Grisham and based on a lab discovery by physician-scientist Dr. David Solit, Ellen got early access to a drug targeting the mutation driving her rare cancer.

The results were dramatic: within four months, Ellen’s cancer had shrunk by 70%.

Read more about this FDA-approved treatment and the years of research that made it possible: https://www.mskcc.org/news/new-drug-treatment-for-low-grade-serous-ovarian-cancer-lgsoc-sparked-by-decade-old-discovery?utm_source=Facebook&utm_medium=Organic+Social+&utm_term=&utm_content=Images+of+Ellen&utm_campaign=Saved+by+Science

02/10/2026

In 2014, Dr. David Solit, a physician-scientist at Memorial Sloan Kettering Cancer Center (MSK), set out to decode the mutations that drive a rare type of ovarian cancer. Nearly 10 years later, that laboratory work became Ellen’s lifeline.

Facing a hard to treat diagnosis that resisted standard care, Ellen joined a clinical trial led by MSK gynecological oncologist Dr. Rachel Grisham -- based on Dr. Solit’s discovery a decade ago.

The results were dramatic. Within four months of taking a drug targeting the mutation, Ellen’s cancer had shrunk by 70%.

Watch more Saved by Science stories on YouTube: https://bit.ly/3ZLODjv

At 31 years old, a colonoscopy would change Sal’s life.After noticing intermittent bleeding in his stool, Sal decided to...
02/09/2026

At 31 years old, a colonoscopy would change Sal’s life.

After noticing intermittent bleeding in his stool, Sal decided to get checked. He was diagnosed with stage 3 colorectal cancer in December 2024. With no family history and no other symptoms, the diagnosis was shocking. “I was confused and lost,” he says.

Sal and his family, who live in New Jersey, turned to MSK Monmouth for care close to home. “Being that MSK is one of the top cancer centers in the world and less than an hour from my home, I knew receiving treatment there was the right option for me,” Sal shares. His care team included colorectal surgeon Dr. Emmanouil Pappou, gastroenterologist Dr. Makoto Nishimura, and medical oncologist Dr. Marina Shcherba, a team Sal says supported him every step of the way.

Before starting chemotherapy, Sal underwent two advanced endoscopic procedures to reduce the size of his tumors. He then completed six rounds of chemotherapy, followed by robotic surgery to remove the cancer. Over the course of several months, all while being a dad to a 3-year-old and continuing to work, Sal stayed focused on one thing: moving forward.

In August 2025, just seven months after being diagnosed, it was Dr. Pappou who shared the words Sal will never forget: “Congratulations, Mr. Giampapa. You are cancer free.”

After completing treatment, Sal and his fiancée welcomed their son, Beau, in November 2025. Today, Sal is back to his daily routine and looking ahead to the future with his growing family. When asked what he would tell someone who is newly diagnosed: “Use all the resources provided to you and do not hesitate to ask for extra support if you need it.”

Leave a 👏 in the comments for Sal!

Employee Spotlight | Brandon Joachim, a clinical nurse at MSK, didn’t have a straightforward path to nursing. He once im...
02/06/2026

Employee Spotlight | Brandon Joachim, a clinical nurse at MSK, didn’t have a straightforward path to nursing. He once imagined a future on the stage.

“I’ve always loved connecting with people — stepping into someone else’s shoes and, for a moment, taking others out of their reality,” says Brandon. “Being on stage gave me a chance to tell stories that felt real and to help the audience feel seen, understood, and transported.”

That same instinct — to understand, comfort, and connect — eventually led him to switch his focus from theater to nursing.

Now celebrating four years at MSK, Brandon works primarily with plastic reconstruction surgery and gynecology patients while also serving as a clinical instructor for nursing students at Pace University, where he went to college.

Brandon explains that his approach to patient care centers on human connection. During his morning assessments, he asks each patient for a book, movie, or music recommendation. “It’s a good way to kind of open up and get to know about the patients, their hobbies and interests. And to help them forget for a moment that they’re in a hospital,” Brandon explains.

When asked what Black History Month means to him, Brandon shares: “For me, it’s a reminder that progress definitely takes time and patience. The past laid the foundation for us, but we still must put in the work to continue to help move things forward, no matter how hard it may feel at times.”

The Josie Robertson Surgery Center (JRSC) at MSK recently celebrated its 10-year anniversary with an eventful evening fi...
02/05/2026

The Josie Robertson Surgery Center (JRSC) at MSK recently celebrated its 10-year anniversary with an eventful evening filled with speakers and refreshments. 🎊

For a decade, the JRSC has transformed how MSK delivers surgical cancer care—demonstrating that world-class outcomes, exceptional patient experience, and operational excellence can thrive together in an outpatient and short-stay setting.

As JRSC marks this milestone anniversary, its impact is clear: safer surgeries, faster recoveries, empowered patients, and a care model that strengthens MSK. By enabling appropriate cases to be shifted to its outpatient and short-stay setting, JRSC has expanded MSK’s capacity and enabled inpatient teams to focus on the most complex cases, without compromising quality.

“When you’re in great pain and learn it’s from cancer, you think, ‘This is it,’” Carlos says. “I never would have believ...
02/04/2026

“When you’re in great pain and learn it’s from cancer, you think, ‘This is it,’” Carlos says. “I never would have believed that two years later I would be feeling fine and being able to do all these things.”

In 2023, Carlos had been given just months to live, when his stage 4 lung cancer spread to the fluid around his brain and spine.

Today, he’s still here, thanks to a collaboration between MSK neuro-oncologist Dr. Adrienne Boire and MSK computational biologist Dr. Dana Pe’er. After a decade of research, the scientists found a way to stop the cancer cells from surviving in the cerebrospinal fluid.

Learn more about the research behind this treatment giving patients, like Carlos, more precious time: https://bit.ly/3NSdUGd

02/03/2026

Carlos was told he had months to live. That was more than two years ago. His entire path changed thanks to breakthrough MSK research that was 10+ years in the making.

Carlos, an MSK lung cancer patient whose cancer had spread to his brain and spinal fluid, enrolled in a clinical trial. It was led by MSK neuro-oncologist Dr. Adrienne Boire and is based on years of research by scientists in the lab of MSK computational biologist Dr. Dana Pe’er.

Carlos' brain and spinal fluid cancer cells are now gone, and he has been given more time with his family and a much better quality of life.

Watch more Saved by Science stories on YouTube: https://bit.ly/3ZLODjv

At one time, cervical cancer was considered one of the most serious cancers for women. But thanks to effective screening...
01/30/2026

At one time, cervical cancer was considered one of the most serious cancers for women. But thanks to effective screening cervical cancer is preventable, and knowing the facts matters.

“The best way to prevent cervical cancer is to get the HPV vaccine,” says Dr. Sarah Kim, a gynecologic surgeon at MSK. “It’s one of the only cancer-preventing vaccines we have and aside from some pain at the injection site, it has no side effects.”

Swipe through to learn how screening and vaccination can help prevent cervical cancer. For more info, visit: https://bit.ly/46kEmhO

Address

New York, NY

Telephone

+13477989213

Website

Alerts

Be the first to know and let us send you an email when Memorial Sloan Kettering Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Memorial Sloan Kettering Cancer Center:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category